Activated Leukocyte Cell Adhesion Molecule and Prognosis in Acute Ischemic Stroke | Zendy

Linda M. Smedbakken | Zendy; Jesper K. Jensen | Zendy; Jonas Hallén | Zendy; Dan Atar | Zendy; James L. Januzzi | Zendy; Bente Halvorsen | Zendy; Pål Aukrust | Zendy; Thor Ueland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Activated Leukocyte Cell Adhesion Molecule and Prognosis in Acute Ischemic Stroke

Author(s) -

Linda M. Smedbakken,

Jesper K. Jensen,

Jonas Hallén,

Dan Atar,

James L. Januzzi,

Bente Halvorsen,

Pål Aukrust,

Thor Ueland

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.612440

Subject(s) - medicine , alcam , stroke (engine) , hazard ratio , quartile , cardiology , troponin , atrial fibrillation , univariate analysis , myocardial infarction , multivariate analysis , cell adhesion molecule , confidence interval , immunology , mechanical engineering , engineering

Biomarkers predicting mortality and functional outcome in stroke may be clinically helpful in identification of patients likely to benefit from intervention. Activated leukocyte cell adhesion molecule (ALCAM) is upregulated during neuroinflammation; we investigated whether ALCAM concentrations are associated with long-term mortality after ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research